Stemina Biomarker Discovery
|
Year Established:
2006 |
|
|
Website:
stemina.com/web/index.php |
|
|
Headquarters:
Madison, Wisconsin, US |
|
|
Company Type:
Small Business (1-10M TTM Revenue) |
|
|
Completed Requests:
10 |
|
Certifications:
|
Stemina has pioneered development of all human, cell-based tests to screen compounds for their potential to cause birth defects or cardiotoxicity. Our devTOX quickPredict assay is highly predictive of developmental toxicity, as shown in a joint US EPA study published in Toxicological Sciences, and is the only commercially available human-based screen. Our Cardio quickPredict assay assesses structural and functional cardiotoxicity with high accuracy, as published in Toxicological Sciences.
| Site | Badges | |
|---|---|---|
| Stemina Biomarker Discovery, Inc. 504 S. Rosa Rd. Madison, Wisconsin, 53719 United States | ||
| Stemina Biomarker Discovery 504 S. Rosa Rd. Madison, Wisconsin, 53719 United States | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.